[go: up one dir, main page]

BG100531A - Метод за инхибиране на фоторазлагането на 3-заместени 2-оксиндоли - Google Patents

Метод за инхибиране на фоторазлагането на 3-заместени 2-оксиндоли

Info

Publication number
BG100531A
BG100531A BG100531A BG10053196A BG100531A BG 100531 A BG100531 A BG 100531A BG 100531 A BG100531 A BG 100531A BG 10053196 A BG10053196 A BG 10053196A BG 100531 A BG100531 A BG 100531A
Authority
BG
Bulgaria
Prior art keywords
substituted
oxidonols
photographs
inhibiting
photodecomposition
Prior art date
Application number
BG100531A
Other languages
Bulgarian (bg)
English (en)
Inventor
Willard Newlin
Sharon Laughlin
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of BG100531A publication Critical patent/BG100531A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Polymerisation Methods In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG100531A 1995-04-24 1996-04-23 Метод за инхибиране на фоторазлагането на 3-заместени 2-оксиндоли BG100531A (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1995/000287 WO1996033701A1 (en) 1995-04-24 1995-04-24 Inhibiting photodecomposition of 3-substituted-2-oxindoles

Publications (1)

Publication Number Publication Date
BG100531A true BG100531A (bg) 1997-06-30

Family

ID=36997502

Family Applications (1)

Application Number Title Priority Date Filing Date
BG100531A BG100531A (bg) 1995-04-24 1996-04-23 Метод за инхибиране на фоторазлагането на 3-заместени 2-оксиндоли

Country Status (30)

Country Link
EP (1) EP0827399A1 (xx)
JP (1) JPH10506635A (xx)
KR (1) KR100189585B1 (xx)
CN (1) CN1053667C (xx)
AP (1) AP607A (xx)
AR (1) AR002728A1 (xx)
AU (1) AU692378B2 (xx)
BG (1) BG100531A (xx)
BR (1) BR9602024A (xx)
CO (1) CO4700418A1 (xx)
FI (1) FI973988A7 (xx)
HR (1) HRP960194A2 (xx)
HU (1) HU216544B (xx)
IL (1) IL117969A0 (xx)
IS (1) IS4339A (xx)
MA (1) MA23848A1 (xx)
NO (1) NO961622L (xx)
NZ (1) NZ286432A (xx)
OA (1) OA10286A (xx)
PE (1) PE34397A1 (xx)
RO (1) RO113305B1 (xx)
RU (1) RU2109510C1 (xx)
SG (1) SG64924A1 (xx)
SI (1) SI9600133A (xx)
SK (1) SK51296A3 (xx)
TR (1) TR199600300A2 (xx)
UA (1) UA42739C2 (xx)
WO (1) WO1996033701A1 (xx)
YU (1) YU25096A (xx)
ZA (1) ZA963210B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3731654B1 (en) 2017-12-29 2024-08-07 Kraft Foods Group Brands LLC Improved oxidative stability of oil-in-water emulsions using natural stabilizers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3136282A1 (de) * 1981-09-12 1983-03-24 Hoechst Ag "verfahren zur stabilisierung photoinstabiler arzneistoffe sowie stabilisierte arzneizubereitungen"
HUT59592A (en) * 1990-07-20 1992-06-29 Egyt Gyogyszervegyeszeti Gyar Process for the preparation of solid medical products
TW438798B (en) * 1992-10-07 2001-06-07 Pfizer 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions

Also Published As

Publication number Publication date
HUP9601057A2 (en) 1997-04-28
RO113305B1 (ro) 1998-06-30
KR960037656A (ko) 1996-11-19
SK51296A3 (en) 1997-04-09
OA10286A (en) 1997-09-19
IS4339A (is) 1996-10-25
AU5085196A (en) 1996-11-07
RU2109510C1 (ru) 1998-04-27
ZA963210B (en) 1997-10-23
WO1996033701A1 (en) 1996-10-31
AP607A (en) 1997-08-27
YU25096A (sh) 1998-08-14
NO961622D0 (no) 1996-04-23
FI973988L (fi) 1997-10-17
CN1139110A (zh) 1997-01-01
UA42739C2 (uk) 2001-11-15
IL117969A0 (en) 1996-08-04
AR002728A1 (es) 1998-04-29
EP0827399A1 (en) 1998-03-11
JPH10506635A (ja) 1998-06-30
BR9602024A (pt) 1998-10-06
SI9600133A (en) 1996-10-31
HUP9601057A3 (en) 1997-05-28
TR199600300A2 (tr) 1996-11-21
CN1053667C (zh) 2000-06-21
AP9600787A0 (en) 1996-04-30
CO4700418A1 (es) 1998-12-29
NO961622L (no) 1996-10-25
HU216544B (hu) 1999-07-28
FI973988A0 (fi) 1997-10-17
FI973988A7 (fi) 1997-10-17
NZ286432A (en) 1998-05-27
AU692378B2 (en) 1998-06-04
SG64924A1 (en) 1999-05-25
PE34397A1 (es) 1997-09-29
KR100189585B1 (ko) 1999-06-01
MA23848A1 (fr) 1996-12-31
HU9601057D0 (en) 1996-06-28
HRP960194A2 (en) 1998-02-28

Similar Documents

Publication Publication Date Title
BR9609744A (pt) Derivados de pirrolidina tendo atividade inibitória de fosfolipase a2
LTPA2016013I1 (lt) 2-okso-1-pirolidino dariniai, jų gamybos būdas ir jų panaudojimas
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
IL116122A0 (en) Intermediates to heterocyclic-cyclic amine derivatives
ES2158537T3 (es) Derivados de acidos ciclopropilalcanoicos.
MY117896A (en) Quinazoline derivatives
TR200100432T2 (tr) Hepatit C inhibitörü tri-peptidler
ES2160949T3 (es) Derivados de fenilen-sulfonamida sustituidos en meta.
DK0894084T3 (da) Kanelsyrederivater og deres anvendelse som integrinantagonister
DE69716810D1 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
ATE149164T1 (de) Neue tetrazolderivate, verfahren zu ihrer herstellung und ihre verwendung
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
DE69330601D1 (de) Serotoninergische ergolin derivate
DE69636393D1 (de) Montirelin zur verhinderung der schlafapnoe
BG100531A (bg) Метод за инхибиране на фоторазлагането на 3-заместени 2-оксиндоли
FI973235L (fi) Menetelmä IL-6:n vaikutusten inhiboimiseksi
PT855398E (pt) Derivados sasquiterpeno tendo actividade antiviral
BR9611572A (pt) Produção de um sal de ácido clavulânico
DK0871632T3 (da) Produktion af et krystallinsk salt af amoxycillin
FI972389A0 (fi) Uusi menetelmä ranitidiinin valmistamiseksi
SE9602416D0 (sv) New forms of an organic salt of N'N-diacetylcystine
NO20004685L (no) Nye forbindelser
DE69528984D1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
DE69410159D1 (de) Neue Verbindung, Leustroducsin H, ihre Herstellung und therapeutische Verwendung
ITMI920720A1 (it) Forma cristallina dell'endo-3-etil-2, 3-diidro-n-(8-metil-8-azabiciclo (3. 2. 1) ott-3-il)- 2-oxo-1h-benzimidazolo-1-carbossamide cloridrato